Results 101 to 110 of about 13,436 (153)

[How I manage relapsed/refractory B-cell acute lymphoblastic leukemia patients treated with CD19 CAR- T cells throughout whole-process management]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang Y.
europepmc   +1 more source

[A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: Integrating clinical characteristics and multiparametric MRI]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Wang Z, Yu S, Zheng H, Tao J, Fan Y, Zhang X.   +5 more
europepmc   +1 more source

肿瘤干细胞标志物CD133在非小细胞肺癌中的 表达及临床意义

Zhongshan Daxue xuebao. Yixue kexue ban, 2008
【目的】 研究肿瘤干细胞标志物CD133在非小细胞肺癌(NSCLC)组织中表达的临床意义?【方法】 用免疫组织化学方法检测77例手术切除的NSCLC组织中CD133的表达,分析CD133表达与患者吸烟指数?组织学类型?组织分化程度?淋巴结转移?肿瘤T分期?N分期和患者预后之间的关系?【结果】 77例NSCLC患者到随访结束时死亡率72.73%(56/77),术后生存时间1～84(s=19)月?3年生存率为32.47%(25/77);无淋巴结结转移组NSCLC的中位生存时间和3年生存率高于有淋巴结转移组(
doaj  

[Primary hepatic neuroendocrine neoplasms: a case series analysis of 10 patients and literature review]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Jiang Y, Meng Y, Zhang S, Wang Y, Wang C, Lu C.   +5 more
europepmc   +1 more source

舌鳞癌VEGF-C表达及癌周淋巴管增殖与颈淋巴结转移的关系 [PDF]

, 2003

core  

咽后淋巴结转移放疗患者生存状况的危险因素分析

Zhongguo shiyan zhenduanxue
目的 分析咽后淋巴结转移放疗患者生存状况的危险因素。方法 采用回顾性分析研究法，对2020年1月—2022年1月期间武汉市第一医院收治的126例咽后淋巴结转移放疗患者展开研究，所有患者均随访至2022年11月，依据患者是否死亡将其分为死亡组(n=38)和存活组(n=88)。对两组患者的各项一般资料和临床资料进行比较，对差异有统计学意义的因素进一步行Logistic多因素分析，明确咽后淋巴结转移放疗患者死亡的危险因素。结果 两组患者的年龄、性别、BMI、吸烟、高脂血症、糖尿病、入院收缩压、入院舒张压 ...
徐莹
doaj  

[Sjögren disease complicated by primary breast lymphoma: A case report]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Ning Y, Zhang X, Li X, Li Y, He J, Jin Y.   +5 more
europepmc   +1 more source

[Chinese expert consensus on the diagnosis and treatment of human immunodeficiency virus infection related diffuse large B cell lymphoma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lymphoid Disease Group, Chinese Society of Hematology, Chinese Medical Association, Lymphoma Integrative Rehabilitation Professional Committee of Chinese Anti-Cancer Association (CACA), Central and Western China AIDS Lymphoma League (CALL), Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO).   +5 more
europepmc   +1 more source

[Establishment of a chronic lymphocytic leukemia mouse model via adoptive transfer of Eμ-TCL1 transgenic splenocytes]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang MX, Guo S, Nadiya A, Xierenguli A, Zhang R, Zeng XJ, Zhang LY, Zhang RR, Qu JH.   +8 more
europepmc   +1 more source

[Autologous hematopoietic stem cell transplantation with TBE conditioning in patients with primary central nervous system lymphoma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chen JL, Ma Y, Zhao RQ, Xiao XB, Chen XL, Yuan SZ, Zhao SH, Lu Y, Gao HH, Wang YQ, Yin H, Cheng NN, Feng P, Bai XR, Huang WR.   +14 more
europepmc   +1 more source